XBiotech (XBIT) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free XBIT Stock Alerts $8.18 +0.23 (+2.89%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media XBiotech Short Interest DataCurrent Short Volume604,500 sharesPrevious Short Volume585,300 sharesChange Vs. Previous Month+3.28%Dollar Volume Sold Short$4.91 millionShort Interest Ratio / Days to Cover10.0Last Record DateMarch 31, 2024Outstanding Shares30,450,000 sharesFloat Size19,740,000 sharesShort Percent of Float3.06%Today's Trading Volume154,375 sharesAverage Trading Volume62,645 sharesToday's Volume Vs. Average246% Short Selling XBiotech ? Sign up to receive the latest short interest report for XBiotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXBIT Short Interest Over TimeXBIT Days to Cover Over TimeXBIT Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… XBiotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024604,500 shares $4.91 million +3.3%3.1%10 $8.13 3/15/2024585,300 shares $3.46 million +8.9%3.0%12.8 $5.91 2/29/2024537,500 shares $3.36 million +35.4%2.7%14.6 $6.26 2/15/2024397,000 shares $2.29 million +5.4%2.0%12.1 $5.78 1/31/2024376,500 shares $1.73 million +9.6%1.9%15.5 $4.59 1/15/2024343,500 shares $1.72 million +1.2%1.7%16.8 $5.00 Get the Latest News and Ratings for XBIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for XBiotech and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023339,400 shares $1.36 million -0.6%1.7%18.9 $4.00 12/15/2023341,500 shares $1.59 million -0.2%1.7%19 $4.65 11/30/2023342,300 shares $1.34 million +9.5%1.8%21.1 $3.92 11/15/2023312,500 shares $1.19 million +6.1%1.7%17.2 $3.80 10/31/2023294,500 shares $1.23 million -1.3%1.6%16.5 $4.18 10/15/2023298,500 shares $1.17 million +7.7%1.6%17.5 $3.93 9/30/2023277,200 shares $1.14 million +9.0%1.5%15.5 $4.12 9/15/2023254,400 shares $1.16 million +72.4%1.4%11.9 $4.55 8/31/2023147,600 shares $726,192.00 -11.9%0.8%5 $4.92 8/15/2023167,600 shares $812,860.00 +9.9%0.9%3.5 $4.85 7/31/2023152,500 shares $767,075.00 -5.8%0.8%1.8 $5.03 7/15/2023161,900 shares $841,880.00 -0.6%0.9%1.8 $5.20 6/30/2023162,800 shares $967,032.00 +4.6%0.9%1.8 $5.94 6/15/2023155,600 shares $955,384.00 +79.1%0.8%1.7 $6.14 5/31/202386,900 shares $442,755.50 +3.7%0.5%1.1 $5.10 5/15/202383,800 shares $279,892.00 +23.1%0.5%1.2 $3.34 4/30/202368,100 shares $234,264.00 -5.0%0.4%2.3 $3.44 4/15/202371,700 shares $255,252.00 -10.0%0.4%2.4 $3.56 3/31/202379,700 shares $274,965.00 +12.7%0.5%2.5 $3.45 3/15/202370,700 shares $238,966.00 -15.0%0.4%2 $3.38 2/28/202383,200 shares $279,552.00 +22.5%0.5%2.1 $3.36 2/15/202367,900 shares $249,193.00 -6.1%0.4%1.7 $3.67 1/31/202372,300 shares $314,505.00 -9.7%0.4%1.9 $4.35 1/15/202380,100 shares $373,266.00 +0.8%0.5%2.1 $4.66 12/30/202279,500 shares $279,045.00 -22.1%0.5%2.1 $3.51 12/15/2022102,000 shares $332,520.00 -27.2%0.6%2.8 $3.26 11/30/2022140,100 shares $453,924.00 +16.9%0.9%3.9 $3.24 11/15/2022119,800 shares $433,676.00 +24.7%0.8%3 $3.62 10/31/202296,100 shares $337,311.00 +42.4%0.6%2.2 $3.51 10/15/202267,500 shares $247,050.00 -11.0%0.4%1.4 $3.66 9/30/202275,800 shares $274,396.00 +9.9%0.5%1.6 $3.62 9/15/202269,000 shares $280,830.00 -22.2%0.4%0.8 $4.07 8/31/202288,700 shares $355,687.00 +9.1%0.6%0.9 $4.01 8/15/202281,300 shares $413,817.00 +89.5%0.5%0.7 $5.09top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… XBIT Short Interest - Frequently Asked Questions What is XBiotech's current short interest? Short interest is the volume of XBiotech shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 604,500 shares of XBIT short. 3.06% of XBiotech's shares are currently sold short. Learn More on XBiotech's current short interest. What is a good short interest ratio for XBiotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XBIT shares currently have a short interest ratio of 10.0. Learn More on XBiotech's short interest ratio. What is a good short interest percentage for XBiotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.06% of XBiotech's floating shares are currently sold short. Is XBiotech's short interest increasing or decreasing? XBiotech saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 604,500 shares, an increase of 3.3% from the previous total of 585,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is XBiotech's float size? XBiotech currently has issued a total of 30,450,000 shares. Some of XBiotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. XBiotech currently has a public float of 19,740,000 shares. How does XBiotech's short interest compare to its competitors? 3.06% of XBiotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to XBiotech: Pyxis Oncology, Inc. (6.93%), Nektar Therapeutics (1.32%), Prelude Therapeutics Incorporated (1.84%), Verastem, Inc. (3.10%), Kamada Ltd. (0.13%), Aquestive Therapeutics, Inc. (3.10%), RAPT Therapeutics, Inc. (8.56%), XOMA Co. (2.36%), Nanobiotix S.A. (0.11%), Foghorn Therapeutics Inc. (6.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short XBiotech stock? Short selling XBIT is an investing strategy that aims to generate trading profit from XBiotech as its price is falling. XBIT shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against XBiotech? A short squeeze for XBiotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIT, which in turn drives the price of the stock up even further. How often is XBiotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIT, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Pyxis Oncology Short Interest Data Nektar Therapeutics Short Interest Data Prelude Therapeutics Short Interest Data Verastem Short Interest Data Kamada Short Interest Data Aquestive Therapeutics Short Interest Data RAPT Therapeutics Short Interest Data XOMA Short Interest Data Nanobiotix Short Interest Data Foghorn Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XBIT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals